Biggest News Aggregation in the World
📰 Specific Populations News

Page 2 - Specific Populations News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Specific Populations. Real-time updates on events, politics, business and more.

Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement f

Takeda Will Be Protagonist's Co-Development, U.S. Co-Commercialization Partner With 50:50 Profit Share, and With Exclusive Ex-U.S. Global Rights to Commercialize Rusfertide, Protagonist's Investigational Injectable Hepcidin Mimetic Currently in Development for the Treatment of Polycythemia Vera (PV)Takeda Will Make...
United States United Kingdom Ann Hematol Dineshv Patel Julie Kim Be Protagonist Co

Takedas GAMMAGARD LIQUID Approved by U.S. FDA for Adults with Chronic Inflammatory Demyelinating Polyneuropathy CIDP

Takeda TSE4502NYSETAK today announced that the U.S. Food and Drug Administration FDA has approved GAMMAGARD LIQUID Immune Globulin Infusion Human 10 solution as an intravenous immunoglobulin IVIG therapy to improve neuromuscular disability and impairment in adults with chronic inflammatory demyelinating polyneuropathy CIDP.
United States Mamatha Pasnoor Lauren Padovan Demyelinating Polyneuropathy Richard Ascroft Takeda Pharmaceutical Company Limited

Takeda's GAMMAGARD LIQUID® Approved by U.S. FDA for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) -January 29, 2024 at 11:11 am EST

New Indication Delivers on Takeda’s Commitment to Expanding its Broad and Diverse Immunoglobulin Portfolio to Meet the Needs of People Living with CIDP Approval Supported by Phase 3...
United States Mamatha Pasnoor Richard Ascroft Demyelinating Polyneuropathy Takeda Pharmaceutical Company Limited University Of Kansas Medical Center

Takeda to Present Data at 65th American Society of Hematology (ASH) Annual Meeting, Demonstrating Continued Commitment to Patients with Hematologic Diseases

Company to Feature 17 Company-Sponsored and Nine Collaborative Abstracts in Oncology and Hematology Hematology Presentations Include New Data from the Phase 3 and Continuation Trials Supporting...
San Diego United States John Cunningham Awny Farajallah German Hodgkin Study Group European Union

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

"They Don't Treat Us like Human Beings" : Abuse of Imprisoned Women in Japan

The 76-page report, “‘They Don’t Treat Us like Human Beings’: Abuse of Imprisoned Women in Japan,” documents the abusive conditions in many women’s prisons in Japan. Government policies towards women in prison violate international human rights conventions and contravene international standards such as the United Nations Standard Minimum Rules of the Treatment of Prisoners, known as the Mandela Rules. Prison authorities use restraints on imprisoned pregnant women, arbitrarily employ ...
Krung Thep Mahanakhon United Kingdom Margaret Wurth Azuha Kikuchi Aki Satouchi Danielle Haas
Source: hrw.org

INPEFA® (sotagliflozin) Use Associated With Early Clinical Benefit in Heart Failure and Atherosclerotic Events in Analysis of Clinical Data

Oral presentation delivered at the American Heart Association (AHA) Scientific Sessions 2023 Analysis of clinical data shows statistically significant risk reductions in heart failure and separately in MACE related outcomes as early as approximately three months in patients at high risk for cardiovascular events INPEFA® (sotagliflozin) recently approved by FDA for treatment of heart failure THE WOODLANDS, Texas, Nov. 12, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) ...
United States Rahul Aggarwal Craig Granowitz Exchange Commission Lexicon Pharmaceuticals Lexicon Pharmaceuticals Inc
Source: yahoo.com

INPEFA® (sotagliflozin) Use Associated With Early Clinical Benefit in Heart Failure and Atherosclerotic Events in Analysis of Clinical Data

Oral presentation delivered at the American Heart Association Scientific Sessions 2023 Analysis of clinical data shows statistically significant risk reductions in heart failure and separately in...
United States Alina Cocuzza Craig Granowitz Rahul Aggarwal Drug Administration Lexicon Pharmaceuticals Inc

INPEFA® (Sotagliflozin) Receives Coverage From Express Scripts on Its Basic and High Performance Formularies for Commercially Insured Patients

As previously reported, Express Scripts has also determined that it will list INPEFA as a preferred product on Medicare national formularies starting today, November 1, 2023 INPEFA recently approved...
United States Alina Cocuzza Exchange Commission Globenewswire Inc Cigna Group Evernorth Lexicon Pharmaceuticals

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science